Slowing of Peripheral Nerve Conduction Velocity in Children and Adolescents With Type 1 Diabetes Is Predicted by Glucose Fluctuations

被引:1
|
作者
Oberhauser, Sarah S. [1 ]
l'Allemand, Dagmar [1 ]
Willems, Erik P. [2 ]
Gozzi, Tiziana [1 ]
Heldt, Katrin [1 ]
Eilers, Miriam [1 ]
Stasinaki, Aikaterini [1 ]
Luetschg, Juerg [3 ,4 ]
Broser, Philip J. [3 ,4 ]
机构
[1] Childrens Hosp Eastern Switzerland, Paediat Endocrinol & Diabetol, St Gallen, Switzerland
[2] Cantonal Hosp, Clin Trials Unit, St Gallen, Switzerland
[3] Childrens Hosp Eastern Switzerland, Paediat Neurol, St Gallen, Switzerland
[4] Univ Basel, Fac Med, Basel, Switzerland
关键词
NEUROPATHY;
D O I
10.2337/db23-0063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nerve conduction velocity (NCV) abnormalities are the forerunners of diabetic peripheral neuropathy (DPN). Therefore, this study aimed to analyze the effect of glucose profile quality on NCV in children and young adults with type 1 diabetes. Fifty-three children age 5 to 23 years with type 1 diabetes were recruited to participate in the study, which was conducted prospectively at the Children's Hospital of Eastern Switzerland from 2016 to 2022. Glycemic targets were recorded, and a cross-sectional nerve conduction study analyzing the peroneal, tibial, median motor, and median sensory nerves was performed. Data were compared with those of a control group of 50 healthy children. In the age- and height-matched diabetes subgroup aged 10-16 years, all four nerves showed significantly slower NCV, most pronounced for the peroneal nerve. Because height has a retarding effect on peroneal NCV, NCV was adjusted for height (dNCV). Peroneal dNCV correlated negatively with long-term glycated hemoglobin and highly significantly with glucose variability. Because high glucose variability clearly increases the risk of neuropathy, together with but also independently of the mean glucose level, this aspect of glycemic control should be given more attention in the care of individuals with diabetes.
引用
收藏
页码:1835 / 1840
页数:7
相关论文
共 44 条
  • [41] Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents With Type 1 Diabetes Mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness
    Adly, Amira Abdel Moneam
    Elbarbary, Nancy Samir
    Ismail, Eman Abdel Rahman
    Hassan, Samar Reda
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (03) : 340 - 347
  • [42] The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes A 24-month, double-blind, randomized, placebo-controlled trial
    Fraser, David A.
    Diep, Lien M.
    Hovden, Inger Anette
    Nilsen, Kristian B.
    Sveen, Kari Anne
    Seljeflot, Ingebjorg
    Hanssen, Kristian F.
    DIABETES CARE, 2012, 35 (05) : 1095 - 1097
  • [43] Expression of CD4+CD28null T lymphocytes in children and adolescents with type 1 diabetes mellitus: Relation to microvascular complications, aortic elastic properties, and carotid intima media thickness
    El-Samahy, Mona H.
    Tantawy, Azza A. G.
    Adly, Amira A. M.
    Habeeb, Nevin M.
    Ismail, Eman A. R.
    Hamed, Gehan M.
    Eladawy, Rasha
    PEDIATRIC DIABETES, 2017, 18 (08) : 785 - 793
  • [44] The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2)
    Louraki, Maria
    Katsalouli, Marina
    Kanaka-Gantenbein, Christina
    Kafassi, Nikolitsa
    Critselis, Eleni
    Kallinikou, Dimitra
    Tsentidis, Charalampos
    Karavanaki, Kyriaki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 117 : 82 - 90